|
About SPP Spring Point Project, LLC (SPP) is a specialized biotechnology support company focused on the production and care of designated pathogen-free (DPF) swine for research and development applications. Through advanced biosecurity practices, specialized animal production facilities, and robust quality systems, SPP supports scientific programs that require high-health source animals and reliable operational excellence. SPP's expertise includes animal husbandry, biosecure facility operations, quality management, and the application of advanced reproductive technologies. By maintaining high standards of animal welfare, quality, and biosafety, SPP provides resources that support the advancement of transplantation-related research and emerging therapeutic technologies. As a wholly owned subsidiary of Otsuka Pharmaceutical Factory America, LLC (OPFA), SPP combines specialized scientific capabilities with the resources and long-term commitment of the Otsuka Group, supporting innovation and progress in future healthcare solutions. |
Type 1 diabetes results from the loss of insulin- producing islet cells in the pancreas. Advances in transplantation and emerging therapeutic technologies depend on the availability of high-quality source animals produced under strict health and biosecurity standards. Through expertise in designated pathogen- free (DPF) swine production, animal care, and biosecure operations, SPP supports research programs focused on transplantation and other innovative healthcare applications. Learn more about the science, specialized capabilities, and quality systems that support our work. |
|
Spring Point Project is a subsidiary of Otsuka Pharmaceutical Factory America. |
